Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: HMP001
MIFTS: 48

Hemopericardium

Categories: Blood diseases, Cardiovascular diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Hemopericardium

About this section

MalaCards integrated aliases for Hemopericardium:

Name: Hemopericardium 12 15 17 71
Pericardial Effusion 43 71
Haemopericardium 12

Classifications:

MalaCards categories:
Anatomical: Cardiovascular diseases Blood diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:11482
ICD9CM 34 423.0
MeSH 43 D010490
NCIt 49 C111644
SNOMED-CT 67 23412002
ICD10 32 I31.2
UMLS 71 C0019064 C0031039
Sources

Summaries for Hemopericardium

About this section
Disease Ontology : 12 A pericardial effusion that results from blood in the pericardial sac.

MalaCards based summary : Hemopericardium, also known as pericardial effusion, is related to pericardial effusion and mediastinitis. An important gene associated with Hemopericardium is F2 (Coagulation Factor II, Thrombin), and among its related pathways/superpathways are Formation of Fibrin Clot (Clotting Cascade) and Complement and coagulation cascades. The drugs Diclofenac and Tadalafil have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and breast, and related phenotypes are cardiovascular system and respiratory system

Wikipedia : 74 Hemopericardium refers to blood in the pericardial sac of the heart. It is clinically similar to a... more...

Sources

Related Diseases for Hemopericardium

About this section

Diseases related to Hemopericardium via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 785)
# Related Disease Score Top Affiliating Genes
1 pericardial effusion 30.9 TNNI3 PVR F3 F2
2 mediastinitis 30.7 F3 F2
3 cardiac tamponade 30.7 TNNI3 PVR PLG F3 F2
4 pleural empyema 30.6 PLG F2
5 exanthem 30.5 F3 F2 CYP3A4
6 tricuspid valve insufficiency 30.5 TNNI3 F3 F2
7 pulmonary embolism 30.4 TNNI3 F3 F2
8 anuria 30.4 F3 F2
9 inferior myocardial infarction 30.3 TNNI3 PLG
10 thrombophlebitis 30.2 PLG F3 F2
11 mitral valve stenosis 30.2 F3 F2
12 esophageal varix 30.2 F3 F2
13 intermediate coronary syndrome 30.1 TNNI3 PLG F3
14 acute myocardial infarction 30.1 TNNI3 PLG F3
15 hemophilia b 30.1 FBN1 F3 F2
16 heart valve disease 30.0 TNNI3 FBN1 F2
17 stroke, ischemic 30.0 PLG FBN1 F3 F2
18 aortic valve insufficiency 30.0 TNNI3 FBN1
19 mitral valve insufficiency 30.0 TNNI3 FBN1 F2
20 thrombosis 30.0 PLG F3 F2
21 mitral valve disease 29.9 TNNI3 FBN1 F3 F2
22 hepatitis a 29.8 F3 F2 CYP3A4
23 angina pectoris 29.7 TNNI3 F3
24 intracranial embolism 29.6 PVR PLG F3 F2
25 tricuspid valve disease 29.5 TNNI3 FBN1 F3 F2
26 atrial heart septal defect 29.4 TNNI3 PVR PLG FBN1 F3 F2
27 atrial fibrillation 29.1 TNNI3 F3 F2
28 hypertension, essential 28.7 TNNI3 PLG FBN1 F3 F2 CYP3A4
29 pericardial effusion, chronic 12.7
30 pericardial tuberculosis 11.7
31 hereditary multiple osteochondromas 11.7
32 cantu syndrome 11.7
33 lymphatic malformation 6 11.6
34 camptodactyly-arthropathy-coxa vara-pericarditis syndrome 11.4
35 congenital disorder of glycosylation, type ia 11.4
36 congenital disorder of glycosylation, type ie 11.4
37 kaposiform lymphangiomatosis 11.4
38 hypothyroidism 10.8
39 pericarditis 10.6
40 aortic dissection 10.5
41 myxedema 10.5
42 constrictive pericarditis 10.5
43 benign mesothelioma 10.5
44 down syndrome 10.5
45 kidney disease 10.5
46 myocarditis 10.5
47 cardiac rupture 10.4
48 atrial standstill 1 10.4
49 pulmonary hypertension 10.4
50 connective tissue disease 10.4

Comorbidity relations with Hemopericardium via Phenotypic Disease Network (PDN):


Aortic Valve Disease 1 Familial Atrial Fibrillation
Heart Disease Intermediate Coronary Syndrome

Graphical network of the top 20 diseases related to Hemopericardium:



Diseases related to Hemopericardium
Sources

Symptoms & Phenotypes for Hemopericardium

About this section

MGI Mouse Phenotypes related to Hemopericardium:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.5 F2 F3 FBN1 HCCS HEG1 PLG
2 respiratory system MP:0005388 9.1 F2 F3 FBN1 HEG1 PLG TNNI3
Sources

Drugs & Therapeutics for Hemopericardium

About this section

Drugs for Hemopericardium (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 150)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
2
Tadalafil Approved, Investigational Phase 4 171596-29-5 110635
3
Ambrisentan Approved, Investigational Phase 4 177036-94-1 6918493
4
Silver sulfadiazine Approved, Vet_approved Phase 4 22199-08-2 441244
5
Treprostinil Approved, Investigational Phase 4 81846-19-7 6918140 54786
6
Colchicine Approved Phase 4 64-86-8 2833 6167
7
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
8
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
9
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
10
Ibuprofen Approved Phase 4 15687-27-1 3672
11
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
12
Dabigatran Investigational Phase 4 211914-51-1
13 Analgesics, Non-Narcotic Phase 4
14 Analgesics Phase 4
15 Cyclooxygenase Inhibitors Phase 4
16 Anti-Inflammatory Agents, Non-Steroidal Phase 4
17 Phosphodiesterase 5 Inhibitors Phase 4
18 Phosphodiesterase Inhibitors Phase 4
19 Antithrombins Phase 4
20 Antithrombin III Phase 4
21 Serine Proteinase Inhibitors Phase 4
22
protease inhibitors Phase 4
23 HIV Protease Inhibitors Phase 4
24 Anticoagulants Phase 4
25 Anti-Inflammatory Agents Phase 4
26 Hormones Phase 4
27 Antineoplastic Agents, Hormonal Phase 4
28 glucocorticoids Phase 4
29 Hormone Antagonists Phase 4
30 Antiemetics Phase 4
31 Gastrointestinal Agents Phase 4
32
Serine Investigational, Nutraceutical Phase 4 56-45-1 5951
33
Cetrorelix Approved, Investigational Phase 2, Phase 3 120287-85-6 16129715 25074887
34
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
35
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
36
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
37
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
38
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
39 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
40
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
41 Fibrinolytic Agents Phase 3
42 Tissue Plasminogen Activator Phase 3
43 Plasminogen Phase 3
44 Sclerosing Solutions Phase 3
45 Methylprednisolone Acetate Phase 3
46 Vaccines Phase 3
47 Tubulin Modulators Phase 3
48 Antirheumatic Agents Phase 3
49 Antimitotic Agents Phase 3
50
Bevacizumab Approved, Investigational Phase 2 216974-75-3

Interventional clinical trials:

(show top 50) (show all 102)
# Name Status NCT ID Phase Drugs
1 Atrial Fibrillation and Pericardial Drainage: Incidence of Postoperative Atrial Fibrillation According to the Type of Mediastinal Drainage Catheters Unknown status NCT02808897 Phase 4
2 Cochicine Treatment for Post- Operative Pericardial Effusion: The POPE 2 Study A Multicenter, Double-blind, Randomized Trial Completed NCT01266694 Phase 4 Colchicines;Placebo
3 the Post Operative Pericardial Effusion (POPE) Treatment Study Completed NCT00247052 Phase 4 diclofenac;diclofenac;matching placebo
4 A Controlled Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Treating Paroxysmal Atrial Fibrillation. The Ablation for Paroxysmal Atrial Fibrillation (APAF2) Trial Completed NCT00340314 Phase 4 Antiarrhythmic Drug Therapy
5 A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis Completed NCT01042158 Phase 4 tadalafil and ambrisentan upfront combination therapy
6 Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Following Catheter Ablation of Atrial Fibrillation Recruiting NCT02260206 Phase 4 Colchicine
7 Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure: the SWISS-APERO Randomized Clinical Trial Recruiting NCT03399851 Phase 4
8 Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension Recruiting NCT03835676 Phase 4 Treprostinil
9 Interventional Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in High-risk Patients With Atrial Fibrillation (PRAGUE-17 Study) Recruiting NCT02426944 Phase 4 NOAC
10 Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study). Active, not recruiting NCT03539055 Phase 4 Dabigatran Etexilate Oral Capsule
11 Dexamethasone Compared to Conventional Therapy in the Treatment of Acute Pericarditis: a Superiority Randomized Controlled Trial (Dexa-P) Not yet recruiting NCT04323280 Phase 4 Dexamethasone therapy;Conventional Therapy
12 A Trial of Complete Percutaneous Pericardial Drainage Facilitated by Intrapericardial Alteplase Compared to Conventional Pericardiocentesis When Indicated in Adults With Large Pericardial Effusion Due to Tuberculous and Non-tuberculous Pericarditis Unknown status NCT02673879 Phase 3
13 COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial). Unknown status NCT01552187 Phase 3 Colchicine;Placebo
14 Sequential E2 Levels Not Ovarian Maximal Diameter Estimates Were Correlated With Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome Unknown status NCT02823080 Phase 2, Phase 3 Cetrorelix
15 A Randomized Controlled Trial to Evaluate the Efficacy of Intra-pericardial Instillation of a Sclerosing Agent After Pericardial Drainage in Patients With Malignant Pericardial Effusion Associated With Lung Cancer (JCOG9811) Completed NCT00132613 Phase 3 Pericardial instillation of bleomycin after drainage
16 A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis Completed NCT00810849 Phase 3 Prednisolone
17 Phase 3 Trial, Randomized, Open-Label, of NOV-002 in Combination With Paclitaxel and Carboplatin vs. Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) Completed NCT00347412 Phase 3 Paclitaxel and Carboplatin;NOV-002 Injection in combination with Carboplatin vs. Paclitaxel and Carboplatin
18 Colchicine Versus Placebo in Post-Cardiac Surgery Patients to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation Terminated NCT02177266 Phase 3 Colchicine;Placebo
19 Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population: A Prospective Randomized Single-center Trial Unknown status NCT02493075 Phase 1, Phase 2
20 Intrapleural Bevacizumab Injection for Treating Malignant Pleural or Pericardial Effusion in Non-small Cell Lung Cancer Completed NCT02054052 Phase 2 Bevacizumab
21 A Pilot Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer Completed NCT00318136 Phase 2 Bevacizumab;Carboplatin;Paclitaxel
22 Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer Completed NCT00251498 Phase 2 Cetuximab
23 Amgen Protocol 20060534 - A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer Completed NCT00791154 Phase 1, Phase 2 AMG 479;Etoposide;Placebo;AMG 102;Carboplatin;Cisplatin
24 A Phase I/II Study to Investigate the Safety, Tolerability and Potential Activity of IPI-504 in Relapsed and / or Refractory Stage IIIb (With Malignant Pleural or Pericardial Effusion), or Stage IV NSCLC Patients Completed NCT00431015 Phase 1, Phase 2 IPI-504
25 NGR014: Randomized Phase II Study of NGR-hTNF in Combination With Standard Chemotherapy Versus Standard Chemotherapy Alone in Previously Untreated Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Completed NCT00994097 Phase 2 NGR-hTNF;Cisplatin;Gemcitabine;Pemetrexed
26 Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in the Treatment of Postmenopausal Women With ER+Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Prior Letrozole or Anastrozole. Completed NCT01783444 Phase 2 Capecitabine;Exemestane;Everolimus
27 A Randomized Phase II Trial of Paclitaxel-Carboplatin or Gemicitabine-Cisplatin in ECOG Performance Status 2 Non-Small Cell Lung Cancer Patients Completed NCT00006004 Phase 2 carboplatin;cisplatin;gemcitabine hydrochloride;paclitaxel
28 Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Stage IV Non-squamous Non Small Cell Lung Cancer (NSCLC) Completed NCT00942825 Phase 2 CBP501 + Cisplatin + Pemetrexed;Cisplatin + Pemetrexed
29 A Phase II Randomized Study of OSI-774 (Erlotinib) (NSC #718781) With or Without Carboplatin/Paclitaxel in Patients With Previously Untreated Adenocarcinoma of the Lung Who Never Smoked or Were Former Light Smokers Completed NCT00126581 Phase 2 Carboplatin;Erlotinib;Erlotinib Hydrochloride;Paclitaxel
30 Single Agent Alimta in Poor Performance Status in Patients With Non-Small Cell Lung Cancer (NSCLC) Completed NCT00508144 Phase 2 Alimta
31 A Phase II Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy Plus Dasatinib (NSC #732517) and Continuation Therapy With Dasatinib Alone in Newly Diagnosed Patients With Core Binding Factor Acute Myeloid Leukemia (AML) Active, not recruiting NCT01238211 Phase 2 Cytarabine;Dasatinib;Daunorubicin Hydrochloride
32 Randomized Phase II Trial of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT and Modern Technology in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Active, not recruiting NCT01507428 Phase 2 18F-Fluoromisonidazole;Carboplatin;Fludeoxyglucose F-18;Paclitaxel
33 Hypofractionated Accelerated Radiotherapy With Concomitant Full Dose Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Phase I/II Study Active, not recruiting NCT02367443 Phase 1, Phase 2
34 Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery : Celiprolol Versus Diltiazem Not yet recruiting NCT03752931 Phase 2 Celiprolol;Diltiazem
35 Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients Suspended NCT02472002 Phase 1, Phase 2
36 Compassionate Use of Catheter Thrombectomy (Aspirex 11F) in Patients With Massive Pulmonary Embolism Terminated NCT00314002 Phase 1, Phase 2
37 Phase II Trial of ILX295501 Administered Orally Once Weekly x 3 Repeated Every 6 Weeks in Patients With Stage III/IV Ovarian Cancer Withdrawn NCT00005645 Phase 2 ILX-295501
38 Phase I Clinical Trial of Autologous Mesothelin Re-directed T Cells in Patients With Chemotherapy Refractory Metastatic Pancreatic Cancer Completed NCT01897415 Phase 1
39 Collagenase Total Occlusion-1 Trial Completed NCT01271335 Phase 1
40 A Phase I Trial of Herceptin and Interleukin-12 Completed NCT00004074 Phase 1
41 A Phase I, Pharmacokinetic, and Biologic Correlative Study of R115777 (NSC 702818) and Herceptin in Patients With Advanced Cancer Completed NCT00005842 Phase 1 tipifarnib
42 Drainage or Pericardiocentesis Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention. Unknown status NCT01665495
43 Clinical Audit of the Management of Pericarditis in Children. Unknown status NCT03253315
44 Functional and Morphological Cardiac Changes in Myeloproliferative Neoplasms Unknown status NCT03177928
45 Improvement of the Etiological Diagnosis of the Pericarditis Unknown status NCT02828085
46 Evaluation of the Cardiac Complications in Congenitally HIV-1 Infected Children in Israel by the Echocardiography and Measurement of N-Terminal Pro-B-Type Natriuretic Peptide (N-BNP). Unknown status NCT00426374
47 The Incidence of Significant Clinical Findings Using Focused Ultrasound Examination for the Heart, Lungs and Abdomen in Elderly Patients Before Emergent Surgery Unknown status NCT02824692
48 The Italian Society of Invasive Cardiology Registry on Percutaneous Aortic Valve Unknown status NCT02713932
49 Placement Of Cardiac PacemaKer Trial (POCKET)-RCT Unknown status NCT02931760
50 A Randomized Comparison of Excimer LASER vs Manual Thrombus Aspiration for the Prevention of No-reflow During Primary Percutaneous Coronary Intervention of St-elevation Myocardial Infarction(LASER-AMI Study) Unknown status NCT01826006

Search NIH Clinical Center for Hemopericardium

Cochrane evidence based reviews: pericardial effusion

Sources

Genetic Tests for Hemopericardium

About this section
Sources

Anatomical Context for Hemopericardium

About this section

MalaCards organs/tissues related to Hemopericardium:

40
Heart, Lung, Breast, T Cells, Liver, Thyroid, Myeloid
Sources

Publications for Hemopericardium

About this section

Articles related to Hemopericardium:

(show top 50) (show all 9038)
# Title Authors PMID Year
1
Prediction of adverse events in patients with initially medically treated type A intramural hematoma. 61
32223964 2020
2
Mid-Term Efficacy of Subxiphoid Versus Transpleural Pericardial Window for Pericardial Effusion. 61
32213328 2020
3
Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions. 61
32345471 2020
4
Primary Mediastinal Large B-Cell Lymphoma in a Child Presenting With Superior Mediastinal Syndrome and Chylous Pleural and Pericardial Effusion. 61
30951026 2020
5
Routine postoperative computed tomography is superior to cardiac ultrasonography for predicting delayed cardiac tamponade. 61
32221770 2020
6
A Pilot Study of Ultrasonography-Naïve Operators' Ability to Use Tele-Ultrasonography to Assess the Heart and Lung. 61
29806509 2020
7
Thromboembolism and bleeding risk in atrial fibrillation ablation with uninterrupted anticoagulation between new oral anticoagulants and vitamin K antagonists: insights from an updated meta-analysis. 61
31686297 2020
8
Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. 61
32174129 2020
9
[Hemoglobin drop after thrombolytic therapy in a 57-year-old stroke patient with "erosive gastritis"]. 61
32533196 2020
10
Fetal aortic valvuloplasty: first report of two cases from Saudi Arabia. 61
32571360 2020
11
Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition. 61
32175673 2020
12
Not just another large atrial septal defect: complex anatomy, challenging procedure, and an unusual complication. 61
32539899 2020
13
[Cardiac Tamponade as Cardio-Oncologic Emergency Disease]. 61
32541160 2020
14
Active chest tube clearance after aortic valve surgery did not influence amount residual pericardial fluid after aortic valve replacement in a randomised trial. 61
32122153 2020
15
Sandwich repair for postinfarction ventricular septal rupture and left ventricular rupture. 61
32529504 2020
16
Echo-Guided Pericardiocentesis: When and How Should It Be Performed? 61
32572594 2020
17
Epicardial Interventions: Impact of Liposomal Bupivacaine on Postprocedural Management (The EPI-LIBRE Study). 61
32496820 2020
18
Subclavian and Axillary Vein Access Versus Cephalic Vein Cutdown for Cardiac Implantable Electronic Device Implantation: A Meta-Analysis. 61
32553216 2020
19
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses. 61
32563654 2020
20
Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation. 61
32553212 2020
21
Status epilepticus as an initial presentation of aortic dissection: A case report. 61
32568141 2020
22
Pleural and Pericardial Effusion as the Only Manifestation of IgG4-Related Disease. 61
32499098 2020
23
Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes. 61
32485042 2020
24
Natural cardiac death after stent implantation with iatrogenic injury of a coronary artery. 61
31713779 2020
25
Giant pericardial-occupying compressive primary cardiac hemangiosarcoma in a cat. 61
32497967 2020
26
Epicardial pacemaker implantation for sick sinus syndrome in a patient with supra vena cava obstructed by a primary cardiac lymphoma. 61
32547661 2020
27
Cardiovascular manifestations in severe and critical patients with COVID-19. 61
32562427 2020
28
Atypical cardiac defects in patients with RASopathies: Updated data on CARNET study. 61
32558384 2020
29
Cardiogenic shock as the initial manifestation of systemic lupus erythematosus. 61
32515553 2020
30
Isolated Exercise-Induced Pulmonary Hypertension Associates with Higher Cardiovascular Risk in Scleroderma Patients. 61
32570917 2020
31
Massive pericardial effusion causing cardiac tamponade accompanied by elevated CA-125 and thoracic lymphadenopathy in sarcoidosis: a case report. 61
32563820 2020
32
Pericardial Effusion and Tamponade Complicating Acute Pericarditis in a Human Metapneumovirus-Infected Adult: A Unique Case Report. 61
32528782 2020
33
Myocardial edema in paroxysmal permeability disorders: The paradigm of Clarkson's disease. 61
32006896 2020
34
Obstructive right ventricular outflow tract myxosarcoma in an adult dog. 61
32464578 2020
35
Transthoracic echocardiography monitoring during ASD closure using an artificial hand system. 61
32552906 2020
36
Diagnosis of a primary pericardial mesothelioma by the combination of conventional echocardiography and contrast echocardiography. 61
32542336 2020
37
Intrapericardial instillation of bleomycin prevents recurrence of malignant pericardial effusions: Series of 46 cases and comprehensive literature review. 61
32513434 2020
38
Early Detection of Localized Immunity in Experimental Autoimmune Myocarditis Using [99mTc]Fucoidan SPECT. 61
31432389 2020
39
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study. 61
31610707 2020
40
[Safety and efficiency of interventional electrophysiology utilizing the German "Belegarztsystem"]. 61
32372229 2020
41
The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. 61
32118615 2020
42
Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis. 61
32283052 2020
43
CT imaging features of COVID-19 pneumonia: initial experience from Turkey. 61
32558645 2020
44
Novel coronavirus disease 2019: predicting prognosis by using a computed tomography severity score and clinicolaboratory data. 61
32500700 2020
45
COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey. 61
32521643 2020
46
A Comprehensive Systemic Literature review of Pericardial Decompression Syndrome: Often Unrecognized and Potentially Fatal Syndrome. 61
32515313 2020
47
Pediatric ventricular assist device therapy for advanced heart failure-Hong Kong experience. 61
31624968 2020
48
Comparing thoracoabdominal injuries of manual versus load-distributing band cardiopulmonary resuscitation. 61
31714472 2020
49
A Case of Profound Hypothyroidism Presenting with Hypertensive Emergency and Large Amount of Pericardial Effusion. 61
32565535 2020
50
Preoperative Mild Pericardial Effusion Is Associated With Perioperative Complications In Elderly Patients Following Hip Fracture Surgery. 61
31475617 2020
Sources

Variations for Hemopericardium

About this section
Sources

Expression for Hemopericardium

About this section
Search GEO for disease gene expression data for Hemopericardium.
Sources

Pathways for Hemopericardium

About this section

Pathways related to Hemopericardium according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Formation of Fibrin Clot (Clotting Cascade) 65
Show member pathways
 11.63 PLG F3 F2
2
Complement and coagulation cascades 36 1
11.29 PLG F3 F2
3
Adhesion 4
10.89 PVR PLG F3
4
Syndecan-4-mediated signaling events 1
10.81 PLG F2
5
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) 65
10.48 PLG F2
Sources

GO Terms for Hemopericardium

About this section

Cellular components related to Hemopericardium according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.5 PVR PLG HEG1 FBN1 F3 F2
2 cell surface GO:0009986 9.46 PVR PLG HEG1 F3
3 collagen-containing extracellular matrix GO:0062023 8.92 PLG FBN1 F3 F2

Biological processes related to Hemopericardium according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.5 PLG FBN1 F2
2 blood coagulation GO:0007596 9.43 PLG F3 F2
3 fibrinolysis GO:0042730 9.16 PLG F2
4 negative regulation of fibrinolysis GO:0051918 8.96 PLG F2
5 hemostasis GO:0007599 8.8 PLG F3 F2

Molecular functions related to Hemopericardium according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 serine-type endopeptidase activity GO:0004252 8.8 PLG F3 F2
Sources

Sources for Hemopericardium

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....